
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (33): 4137-4142.DOI: 10.12114/j.issn.1007-9572.2023.0116
Special Issue: 老年问题最新文章合辑; 心肌梗死最新文章合辑; 老年人群健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2023-01-19
Revised:2023-05-11
Published:2023-11-20
Online:2023-05-28
Contact:
ZHAO Xin
About author:
通讯作者:
赵昕
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0116
| 组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI 〔M(P25,P75),kg/m2〕 | 血压分级〔例(%)〕 | 糖尿病〔例(%)〕 | |||
|---|---|---|---|---|---|---|---|---|---|
| 正常 | 1级 | 2级 | 3级 | ||||||
| 未死亡组 | 1 315 | 791/524 | 72.3±8.1 | 25.2(23.0,27.4) | 392(29.80) | 254(19.30) | 163(12.40) | 506(38.50) | 566(43.04) |
| 死亡组 | 108 | 60/48 | 79.4±8.9 | 24.0(22.2,25.4) | 36(33.30) | 15(13.90) | 10(9.30) | 47(43.50) | 56(51.90) |
| 检验统计量值 | 0.877a | -8.560b | -4.198c | 3.426c | 3.148a | ||||
| P值 | 0.349 | <0.001 | <0.001 | 0.330 | 0.076 | ||||
| 组别 | 糖尿病〔例(%)〕 | PLR 〔M(P25,P75)〕 | 白细胞计数〔M(P25,P75),×109/L〕 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | 红细胞计数〔M(P25,P75),×109/L〕 | |||
| 未死亡组 | 566(43.04) | 136.25(106.21,178.44) | 7.24(5.85,8.87) | 4.95(3.82,6.52) | 1.46(1.13,1.89) | 4.34(3.94,4.71) | |||
| 死亡组 | 56(51.90) | 179.30(124.81,257.62) | 10.36(7.93,13.80) | 8.17(5.75,11.54) | 1.11(0.72,1.70) | 3.91(3.47,4.33) | |||
| 检验统计量值 | 3.148a | -5.566c | -8.758c | -10.076c | -5.673c | -5.900c | |||
| P值 | 0.076 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||
| 组别 | 血小板计数〔M(P25,P75),109/L〕 | 血红蛋白〔M(P25,P75),g/L〕 | 空腹血糖〔M(P25,P75),mmol/L〕 | HbA1c 〔M(P25,P75),%〕 | AST 〔M(P25,P75),U/L〕 | ||||
| 未死亡组 | 203.00(171.00,240.00) | 131.00(119.00,142.00) | 6.41(5.33,8.83) | 6.30(5.80,7.60) | 27.89(19.35,61.69) | ||||
| 死亡组 | 208.50(171.75,252.50) | 118.00(104.00,132.00) | 7.85(5.98,12.10) | 6.25(5.90,7.85) | 88.21(29.04,236.76) | ||||
| 检验统计量值 | -0.577c | -5.912c | -4.401c | -0.112c | -6.717c | ||||
| P值 | 0.564 | <0.001 | <0.001 | 0.911 | <0.001 | ||||
| 组别 | TC〔M(P25,P75),mmol/L〕 | LDL-C〔M(P25,P75),mmol/L〕 | HDL-C〔M(P25,P75),mmol/L〕 | RC〔M(P25,P75),mmol/L〕 | TG〔M(P25,P75),mmol/L〕 | CK-MB〔M(P25,P75),μg/L〕 | |||
| 未死亡组 | 4.36(3.63,5.18) | 2.41(1.85,3.04) | 1.04(0.91,1.21) | 0.80(0.62,1.03) | 1.34(0.98,1.84) | 19.35(14.85,38.44) | |||
| 死亡组 | 4.34(3.45,5.39) | 2.30(1.82,3.09) | 1.09(0.88,1.29) | 0.83(0.62,1.29) | 1.15(0.91,1.61) | 28.13(6.77,111.01) | |||
| 检验统计量值 | -0.170c | -0.442c | -1.210c | -0.816c | -2.591c | -1.024c | |||
| P值 | 0.865 | 0.658 | 0.226 | 0.415 | 0.010 | 0.306 | |||
| 组别 | CTNI 〔M(P25,P75),μg/L〕 | eGFR分级〔例(%)〕 | 合并心力衰竭〔例(%)〕 | 使用抗血小板类药物〔例(%)〕 | 使用降脂类药物〔例(%)〕 | ||||
| <30 mL·min-1· (1.73 m2)-1 | 30~60 mL·min-1· (1.73 m2)-1 | >60 mL·min-1· (1.73 m2)-1 | |||||||
| 未死亡组 | 0.96(0.51,2.51) | 193(14.70) | 157(11.90) | 965(73.40) | 866(65.90) | 1 234(93.80) | 1 289(98.00) | ||
| 死亡组 | 5.51(0.80,20.00) | 35(32.40) | 37(34.30) | 36(33.30) | 101(93.50) | 91(84.30) | 98(90.70) | ||
| 检验统计量值 | -7.125c | 78.811a | 35.072a | 14.287a | 21.463a | ||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||
Table 1 Comparison of baseline data of two groups
| 组别 | 例数 | 性别(男/女) | 年龄(岁) | BMI 〔M(P25,P75),kg/m2〕 | 血压分级〔例(%)〕 | 糖尿病〔例(%)〕 | |||
|---|---|---|---|---|---|---|---|---|---|
| 正常 | 1级 | 2级 | 3级 | ||||||
| 未死亡组 | 1 315 | 791/524 | 72.3±8.1 | 25.2(23.0,27.4) | 392(29.80) | 254(19.30) | 163(12.40) | 506(38.50) | 566(43.04) |
| 死亡组 | 108 | 60/48 | 79.4±8.9 | 24.0(22.2,25.4) | 36(33.30) | 15(13.90) | 10(9.30) | 47(43.50) | 56(51.90) |
| 检验统计量值 | 0.877a | -8.560b | -4.198c | 3.426c | 3.148a | ||||
| P值 | 0.349 | <0.001 | <0.001 | 0.330 | 0.076 | ||||
| 组别 | 糖尿病〔例(%)〕 | PLR 〔M(P25,P75)〕 | 白细胞计数〔M(P25,P75),×109/L〕 | 中性粒细胞计数〔M(P25,P75),×109/L〕 | 淋巴细胞计数〔M(P25,P75),×109/L〕 | 红细胞计数〔M(P25,P75),×109/L〕 | |||
| 未死亡组 | 566(43.04) | 136.25(106.21,178.44) | 7.24(5.85,8.87) | 4.95(3.82,6.52) | 1.46(1.13,1.89) | 4.34(3.94,4.71) | |||
| 死亡组 | 56(51.90) | 179.30(124.81,257.62) | 10.36(7.93,13.80) | 8.17(5.75,11.54) | 1.11(0.72,1.70) | 3.91(3.47,4.33) | |||
| 检验统计量值 | 3.148a | -5.566c | -8.758c | -10.076c | -5.673c | -5.900c | |||
| P值 | 0.076 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |||
| 组别 | 血小板计数〔M(P25,P75),109/L〕 | 血红蛋白〔M(P25,P75),g/L〕 | 空腹血糖〔M(P25,P75),mmol/L〕 | HbA1c 〔M(P25,P75),%〕 | AST 〔M(P25,P75),U/L〕 | ||||
| 未死亡组 | 203.00(171.00,240.00) | 131.00(119.00,142.00) | 6.41(5.33,8.83) | 6.30(5.80,7.60) | 27.89(19.35,61.69) | ||||
| 死亡组 | 208.50(171.75,252.50) | 118.00(104.00,132.00) | 7.85(5.98,12.10) | 6.25(5.90,7.85) | 88.21(29.04,236.76) | ||||
| 检验统计量值 | -0.577c | -5.912c | -4.401c | -0.112c | -6.717c | ||||
| P值 | 0.564 | <0.001 | <0.001 | 0.911 | <0.001 | ||||
| 组别 | TC〔M(P25,P75),mmol/L〕 | LDL-C〔M(P25,P75),mmol/L〕 | HDL-C〔M(P25,P75),mmol/L〕 | RC〔M(P25,P75),mmol/L〕 | TG〔M(P25,P75),mmol/L〕 | CK-MB〔M(P25,P75),μg/L〕 | |||
| 未死亡组 | 4.36(3.63,5.18) | 2.41(1.85,3.04) | 1.04(0.91,1.21) | 0.80(0.62,1.03) | 1.34(0.98,1.84) | 19.35(14.85,38.44) | |||
| 死亡组 | 4.34(3.45,5.39) | 2.30(1.82,3.09) | 1.09(0.88,1.29) | 0.83(0.62,1.29) | 1.15(0.91,1.61) | 28.13(6.77,111.01) | |||
| 检验统计量值 | -0.170c | -0.442c | -1.210c | -0.816c | -2.591c | -1.024c | |||
| P值 | 0.865 | 0.658 | 0.226 | 0.415 | 0.010 | 0.306 | |||
| 组别 | CTNI 〔M(P25,P75),μg/L〕 | eGFR分级〔例(%)〕 | 合并心力衰竭〔例(%)〕 | 使用抗血小板类药物〔例(%)〕 | 使用降脂类药物〔例(%)〕 | ||||
| <30 mL·min-1· (1.73 m2)-1 | 30~60 mL·min-1· (1.73 m2)-1 | >60 mL·min-1· (1.73 m2)-1 | |||||||
| 未死亡组 | 0.96(0.51,2.51) | 193(14.70) | 157(11.90) | 965(73.40) | 866(65.90) | 1 234(93.80) | 1 289(98.00) | ||
| 死亡组 | 5.51(0.80,20.00) | 35(32.40) | 37(34.30) | 36(33.30) | 101(93.50) | 91(84.30) | 98(90.70) | ||
| 检验统计量值 | -7.125c | 78.811a | 35.072a | 14.287a | 21.463a | ||||
| P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | ||||
| 变量 | AUC | 95%CI | 灵敏度 | 特异度 | Z值 | P值 |
|---|---|---|---|---|---|---|
| PLR | 0.661 | (0.636,0.685) | 0.482 | 0.789 | 5.596 | <0.001 |
| PLR+CK-MB | 0.705 | (0.681,0.729) | 0.657 | 0.663 | 7.799 | <0.001 |
| PLR+CTNI | 0.779 | (0.756,0.800) | 0.729 | 0.714 | 11.310 | <0.001 |
Table 2 Comparison of area under ROC curve of different indicators
| 变量 | AUC | 95%CI | 灵敏度 | 特异度 | Z值 | P值 |
|---|---|---|---|---|---|---|
| PLR | 0.661 | (0.636,0.685) | 0.482 | 0.789 | 5.596 | <0.001 |
| PLR+CK-MB | 0.705 | (0.681,0.729) | 0.657 | 0.663 | 7.799 | <0.001 |
| PLR+CTNI | 0.779 | (0.756,0.800) | 0.729 | 0.714 | 11.310 | <0.001 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
马丽媛,王增武,樊静,等. 《中国心血管健康与疾病报告2021》关于中国高血压流行和防治现状[J]. 中国全科医学,2022,25(30):3715-3720. DOI:10.12114/j.issn.1007-9572.2022.0502.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [1] | ZHAO Yuanyuan, LIU Pulin, DAI Juan, ZHANG Gang, ZHANG Wei, ZHANG Xiaoxia, DENG Qing, YAN Yaqiong. Association Study between Chinese Visceral Adiposity Index and Risk of All-cause and Cause-specific Mortality in the Elderly [J]. Chinese General Practice, 2026, 29(26): 3781-3787. |
| [2] | SUN Qinyu, DENG Yifan, YU Jiling, CAO Gan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Study on the Predictive Value of Cumulative LDL-C Exposure and Uric Acid/HDL-C Ratio in Elderly Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(24): 3447-3453. |
| [3] | WU Liyun, SUN Huajing, GU Yiqing, MEI Ziqi, JIN Shengji, ZHANG Suju, ZHU Yun, ZHANG Yao, LI Qin, LIU Xiaomiao, WANG Qing, BAI Yamei, XU Guihua. Application of Digital-intelligent Technology in Electrocardiographic Monitoring for Acute Myocardial Infarction: a Scoping Review [J]. Chinese General Practice, 2026, 29(24): 3545-3552. |
| [4] | ZHANG Ji, LI Ling, ZHOU Jie, WU Yanli, JI Wei, LIU Tao. A Prospective Cohort Study on Relationship between Lipid Accumulation Product and Incidence of Metabolic Syndrome in Adults [J]. Chinese General Practice, 2026, 29(22): 3138-3145. |
| [5] | YUAN Yujuan, TAO Jing, WANG Ying, PENG Hui, YANG Yining. Elevated Neutrophil Percentage to Albumin Ratio is Associated with In-hospital Outcomes in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(18): 2489-2497. |
| [6] | ZHANG Yanjing, ZHOU Chunhua, LI Xiaodong, LIU Yan, WANG Jing, YU Jing. Study on the Clinical Value of a Risk Prediction Model for Venlafaxine Plasma Concentration Exceeding the Safety Threshold [J]. Chinese General Practice, 2026, 29(06): 777-782. |
| [7] | WANG Lina, LEI Jingshu, LI Kuibao, WANG Ruiying, LI Xinmiao, WANG Fangfang, GUO Xiaorong, NIU Ruihao, ZHAO Wei, ZHOU Fangfang, ZHAO Jingjing, LEE CHONGYOU. Review on Inflammatory Response in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2026, 29(06): 790-801. |
| [8] | CEN Kaiyuan, FATIMAH Ahmedy, CHEN Hong, SHAO Mingchen, MEXMOLLEN Marcus, MOHD Fadzli Shukor. Exercise-based Cardiac Rehabilitation in Acute Myocardial Infarction Management: Global Perspectives, Multimodal Interventions, and Personalized Strategies [J]. Chinese General Practice, 2025, 28(36): 4627-4639. |
| [9] | ZHAO Zhuo, WANG He. Research Progress on the Mechanism of HIF-2α in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(33): 4241-4248. |
| [10] | LI Shunan, ZHANG Shiyan, DENG Yanan, HU Danqing, ZHENG Yuxin, LI Danyang, LI Candong. An Analysis of Trends and Prediction of Disease Burden for Type 2 Diabetic Nephropathy from 1990 to 2021 in China [J]. Chinese General Practice, 2025, 28(33): 4214-4226. |
| [11] | JIA Gaopeng, CHEN Qiuyu. Construction and Validation of a Risk Prediction Model for Recurrent Angina after Percutaneous Coronary Intervention in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction: Based on CYP2C19-related Genetic Testing [J]. Chinese General Practice, 2025, 28(30): 3779-3786. |
| [12] | ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali. Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(29): 3653-3659. |
| [13] | YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263. |
| [14] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
| [15] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||